Is Osteopathic Manipulative Treatment (OMT) Beneficial for Elderly Patients Hospitalized With Pneumonia?

NCT00258661 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 406

Last updated 2018-10-04

No results posted yet for this study

Summary

Osteopathic Manipulative Treatment (OMT) were used in the 1800s and 1900s to treat pneumonia before the introduction of antibiotics in the mid-1900s. The purpose of this study is to determine if OMT, when used in conjunction with antibiotics and other usual care, will improve the recovery of elderly pneumonia patients.

Conditions

Interventions

PROCEDURE

Osteopathic Manipulative Treatment

In addition to conventional treatment for pneumonia, a 10-minute standardized OMT protocol + 5-minute nonstandardized component was performed twice daily for the duration of hospitalization.

PROCEDURE

Light-touch Treatment

In addition to conventional treatment for pneumonia, a 10-minute standardized light-touch protocol (designed to mimic OMT standardized protocol) + 5-minute auscultation of carotid bruits, heart, and lungs was performed twice daily for the duration of hospitalization.

Sponsors & Collaborators

  • Brentwood Foundation

    collaborator OTHER
  • Colorado Springs Osteopathic Foundation

    collaborator OTHER
  • Foundation for Osteopathic Health Services (Maryland)

    collaborator UNKNOWN
  • Muskegon General Osteopathic Foundation (Michigan)

    collaborator UNKNOWN
  • Northwest Oklahoma Osteopathic Foundation (Oklahoma)

    collaborator UNKNOWN
  • Osteopathic Founders Foundation (Oklahoma)

    collaborator UNKNOWN
  • Osteopathic Institute of the South (Georgia)

    collaborator UNKNOWN
  • Osteopathic Heritage Foundations

    collaborator OTHER
  • Quad City Osteopathic Foundation (Iowa)

    collaborator UNKNOWN
  • A.T. Still University of Health Sciences

    lead OTHER

Principal Investigators

  • Donald R Noll, D.O., FACOI · A.T. Still University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-03-31
Primary Completion
2007-04-30
Completion
2007-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00258661 on ClinicalTrials.gov